Focal nodular hyperplasia: Lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study

Journal of Magnetic Resonance Imaging

Volumn 24, Issue 4, 2006, Pages 864-872

  Terkivatan, Türkan ^a   Van Den Bos, Indra C ^a   Hussain, Shahid M ^a,b   Wielopolski, Piotr A ^a   De Man, Rob A ^a   Ijzermans, Jan N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Contrast; Focal nodular hyperplasia; Liver; MRI; SPIO

Indexed keywords

CONTRAST MEDIUM; FERROCARBUTAN; GADOLINIUM; GADOLINIUM PENTETATE; SUPERPARAMAGNETIC IRON OXIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTERY; ARTICLE; BLACK BLOOD ECHO PLANAR IMAGING; CELL INFILTRATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG UPTAKE; ECHO PLANAR IMAGING; EVALUATION; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE INTENSIFIER; LIVER INJURY; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCAR; SIGNAL NOISE RATIO; T1 WEIGHTED IMAGING; T2 WEIGHTED IMAGING;

ADULT; AGED; CONTRAST MEDIA; DEXTRANS; FEMALE; FERROSOFERRIC OXIDE; FOCAL NODULAR HYPERPLASIA; GADOLINIUM DTPA; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MIDDLE AGED; OXIDES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 33749622424     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20705     Document Type: Article

References (26)

1. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999;23:1441-1454.
2. Chamy CK, Jarnagin WR, Schwartz LH, et al. Management of 155 patients with benign liver tumours. Br J Surg 2001;88:808-813.
3. Terkivatan T, de Wilt JH, De Man RA, et al. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001;136:1033-1038.
4. Paradis V, Benzekri A, Dargere D, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004;126:1323-1329.
5. Mortele KJ, Praet M, Van Vlierberghe H, Kunnen M, Ros PR. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic- pathologic correlation. AJR Am J Roentgenol 2000;175:687-692.
6. Martin DR, Semelka RC. Imaging of benign and malignant focal liver lesions. Magn Reson Imaging Clin N Am 2001;9:785-802.
7. Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001;13:397-401.
8. Mahfouz AE, Hamm B, Taupitz M, Wolf KJ. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 1993;186:133-138.
9. Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, De Man RA, Krestin GP. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 2002;22:1023-1036.
10. Hussain SM, Terkivatan T, Zondervan PE, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004;24:3-17.
11. Marti-Bonmati L, Casillas C, Dosda R. Enhancement characteristics of hepatic focal nodular hyperplasia and its scar by dynamic magnetic resonance imaging. MAGMA 2000;10:200-204.
12. Mathieu D, Vilgrain V, Mahfouz AE, Anglade MC, Vullierme MP, Denys A. Benign liver tumors. Magn Reson Imaging Clin N Am 1997;5:255-288.
13. Motohara T, Semelka RC, Nagase L. MR imaging of benign hepatic tumors. Magn Reson Imaging Clin N Am 2002;10:1-14.
14. Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology 2001;218:27-38.
15. Helmberger T, Semelka RC. New contrast agents for imaging the liver. Magn Reson Imaging Clin N Am 2001;9:745-766.
16. Scharitzer M, Schima W, Schober E, et al. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging. J Comput Assist Tomogr 2005;29:181-190.
17. Precetti-Morel S, Bellin MF, Ghebontni L, et al. Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR Imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences. Eur Radiol 1999;9:1535-1542.
18. Paley MR, Mergo PJ, Torres GM, Ros PR. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. AJR Am J Roentgenol 2000;175:159-163.
19. Ba-Ssalamah A, Schima W, Schmook MT, et al. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol 2002;179:1447-1456.
20. Kim JH, Kim MJ, Suh SH, Chung JJ, Yoo HS, Lee JT. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 2002;15:573-583.
21. Takahama K, Amano Y, Hayashi H, Ishihara M, Kumazaki T. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxldes-enhanced T1-weighted Imaging and delayed-phase gadolinium-enhanced T1-weighted imaging. Abdom Imaging 2003;28:525-530.
22. Prasad SR, Wang H, Rosas H, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics 2005;25:321-331.
23. Elsayes KM, Narra VR, Yin Y, Mukundan G, Lammle M, Brown JJ. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. Radiographics 2005;25:1299-1320.
24. Hussain SM, Semelka RC. Liver masses. Magn Reson Imaging Clin N Am 2005;13:255-275.
25. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PI, Borel RI, Wiggers T. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 1997;203:449-456.
26. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005;236:166-177.